Cargando…

Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic

Detalles Bibliográficos
Autores principales:	Matsuo, Koji, Shimada, Muneaki, Matsuzaki, Shinya, Enomoto, Takayuki, Mikami, Mikio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966971/ https://www.ncbi.nlm.nih.gov/pubmed/33743479 http://dx.doi.org/10.1016/j.ejca.2021.02.013

Ejemplares similares

Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study
por: Matsuo, Koji, et al.
Publicado: (2019)

Ovarian conservation for young women with clinical stage IB–IIB cervical cancer in Japan
por: Matsuo, Koji, et al.
Publicado: (2017)

Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2017)

Wait-time for hysterectomy and survival of women with early-stage cervical cancer: A clinical implication during the coronavirus pandemic
por: Matsuo, Koji, et al.
Publicado: (2020)

Association between definitive chemoradiotherapy wait-time and survival in locally-advanced cervical cancer: Implications during the coronavirus pandemic
por: Matsuo, Koji, et al.
Publicado: (2021)

Effect of delay in surgical therapy for early-stage cervical cancer: An implication in the coronavirus pandemic
por: Matsuo, Koji, et al.
Publicado: (2020)

Association between hysterectomy wait-time and all-cause mortality for micro-invasive cervical cancer: treatment implications during the coronavirus pandemic
por: Matsuo, Koji, et al.
Publicado: (2021)

Trachelectomy for stage IB1 cervical cancer with tumor size >2 cm: trends and characteristics in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study
por: Shigeta, Shogo, et al.
Publicado: (2023)

Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB–IIB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy with Taxane and Platinum Followed by Radical Hysterectomy for Stage IB2-IIB Cervical Cancer: Impact of Histology Type on Survival
por: Matsuo, Koji, et al.
Publicado: (2019)

Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
por: Machida, Hiroko, et al.
Publicado: (2019)

Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB–IIB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2018)

Proposal of a Two-Tier System in Grouping Adenocarcinoma of the Uterine Cervix
por: Machida, Hiroko, et al.
Publicado: (2020)

Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer
por: Matsuo, Koji, et al.
Publicado: (2019)

Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan
por: Machida, Hiroko, et al.
Publicado: (2019)

Waiting time for radiotherapy in women with cervical cancer
por: do Nascimento, Maria Isabel, et al.
Publicado: (2016)

Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study
por: Seino, Manabu, et al.
Publicado: (2022)

Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system
por: Machida, Hiroko, et al.
Publicado: (2022)

Evaluation of Surgical Approaches and Use of Adjuvant Radiotherapy with Respect to Oncologic Outcomes in the Management of Clinically Early-Stage Cervical Carcinoma
por: Burgess, Laura, et al.
Publicado: (2022)

Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas
por: Matsuo, Koji, et al.
Publicado: (2023)

Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG/TGCU Intergroup Surveillance
por: SHIMADA, MUNEAKI, et al.
Publicado: (2013)

Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
por: Chai, Yanlan, et al.
Publicado: (2014)

Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology
por: Ushijima, Kimio, et al.
Publicado: (2023)

Changes in the Clinicopathological Demographics of Vulvar Cancer in Japan: Increasing Oldest-Old, Stage Shifting, and Decreasing Cohort-Level Survival †
por: Nishio, Shin, et al.
Publicado: (2019)

An Attempt to Develop a New Treatment Strategy for Rare Refractory Gynecological Malignancies: The Japanese Gynecologic Oncology Group
por: Shigeta, Shogo, et al.
Publicado: (2023)

Cost-effectiveness of radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
por: Chai, Yanlan, et al.
Publicado: (2016)

Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer
por: Mikami, Mikio, et al.
Publicado: (2018)

Analysis of pathological and clinical characteristics of cervical conization according to age group in Japan
por: Murakami, Isao, et al.
Publicado: (2020)

Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study
por: Machida, Hiroko, et al.
Publicado: (2021)

Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study
por: Kondo, Eiji, et al.
Publicado: (2021)

Association of menopause, aging and treatment procedures with positive margins after therapeutic cervical conization for CIN 3: a retrospective study of 8,856 patients by the Japan Society of Obstetrics and Gynecology
por: Ikeda, Masae, et al.
Publicado: (2021)

Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate‐risk group
por: Taguchi, Ayumi, et al.
Publicado: (2023)

Oncologic outcomes of postoperative adjuvant versus salvage radiotherapy in prostate cancer
por: Şendoğan, Furkan, et al.
Publicado: (2023)

Oncologic Nomogram for Stage I Rectal Cancer to Assist Patient Selection for Adjuvant (Chemo)Radiotherapy Following Local Excision
por: Zhao, Shutao, et al.
Publicado: (2021)

Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB–IIA cervical cancer patients
por: Lee, Kwang-Beom, et al.
Publicado: (2018)

An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group
por: Shimada, Muneaki, et al.
Publicado: (2023)

Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma
por: Egawa‐Takata, Tomomi, et al.
Publicado: (2022)

Adjuvant Radiotherapy After Minimally Invasive Surgery in Patients With Stage IA1-IIA1 Cervical Cancer
por: Gan, Yi-xiu, et al.
Publicado: (2021)

The 61st Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO)
por: Yoshihara, Kosuke, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c6n1d9ldtrbg052fdr04fl98b0